Read E.V.I.dently Today for current news about health policy and events, among other topics.
E.V.I.dently Today Blog
As the US health care system continues to transition from volume to value, NPC/Duke-Margolis research shows that value-based agreements between payers and biopharmaceutical manufacturers may be more prevalent than previously assumed.
NPC in Specialty Pharmacy Times: How Can We Advance Progress in Moving from Volume to Value in Health Care?
In his latest column in Specialty Pharmacy Times, NPC President and Chief Executive Officer Dan Leonard explains that rather than trying to score news headlines, what we need is a thoughtful, research-based approach to tackle the health care challenges ahead of us.
A study published in Value in Health by IQVIA and NPC takes a deeper dive on the data sources and methods behind a wide range of prescription medicine spending estimates cited by five different health care organizations.
In an article published in The Patient, NPC and the National Health Council found that while most patients were initially unaware of real-world evidence (RWE) and its actual or potential uses, patients see great potential in using RWE and think it should be used to inform decision-making. The article flags key areas that would make RWE more useful and accessible to patients.
In his latest column for Chain Drug Review, National Pharmaceutical Council President and Chief Executive Officer Dan Leonard looks deeper into 2019 and explores how we can take a more holistic approach toward addressing health care spending and getting it under control.
Study Finds That Costs Dropped, Outcomes Improved for Major Causes of Death and Illness Between 1995 and 2015
Spending for six of the top seven causes of death and disease over the last 20 years was both cost-effective and improved patient outcomes, according to a study from NPC and RTI Health Solutions published in the January 2019 issue of Health Affairs.